NCT04319926View on ClinicalTrials.gov

Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 7, 2018

Primary Completion Date

September 9, 2018

Study Completion Date

September 9, 2018

Conditions

Healthy

Interventions

DRUG

lidocaine topical system 1.8%

One topical system is applied to the subject's back for 12 hours.

DRUG

lidocaine patch 5%

One generic lidocaine patch is applied to the subject's back for 12 hours.

Trial Locations (1)

56529

AXIS Clinicals, Dilworth

All Listed Sponsors

lead

Scilex Pharmaceuticals, Inc.

INDUSTRY

NCT04319926 - Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects | Biotech Hunter | Biotech Hunter